Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
137 hedge funds and large institutions have $1.12B invested in Abiomed Inc in 2014 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 12 closing their positions.
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
51% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 37
9% more funds holding
Funds holding: 126 → 137 (+11)
7% more capital invested
Capital invested by funds: $1.05B → $1.12B (+$75.9M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
42% less call options, than puts
Call options by funds: $686K | Put options by funds: $1.18M
Top Buyers
Top Sellers
ABMD Hedge Fund Activity: Q1 2014 in Review
137 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2014, worth a combined $1.12B — up 7.3% from $1.05B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ABMD positions and 12 closed out — a net gain of 13 holders — while 56 added to existing stakes and 37 trimmed.
The largest buyer was Assured Investment Management, opening a new position worth an estimated $44.5M. The largest seller was Palo Alto Investors, cutting an estimated $13.4M.
- 137 institutional investors held Abiomed Inc (ABMD) as of Q1 2014, up from 126 in Q4 2013.
- Funds reported $1.12B of Abiomed Inc stock for Q1 2014, up 7.3% quarter-over-quarter.
- 25 funds opened new Abiomed Inc positions in Q1 2014 and 12 closed out, a net change of +13 holders.
- The largest Abiomed Inc buyer in Q1 2014 was Assured Investment Management, an estimated $44.5M added.
- The largest Abiomed Inc seller in Q1 2014 was Palo Alto Investors, an estimated $13.4M sold.
Based on aggregated 13F filings for Q1 2014.